The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm

Sven F. Seys; Merete B. Long

doi:10.1183/13993003.02669-2021

The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm

Sven F. Seys (Lead / Corresponding author), Merete B. Long

Molecular and Clinical Medicine

Research output: Contribution to journal › Review article › peer-review

2 Citations (Scopus)

Abstract

It is increasingly evident that the airway inflammatory environment in patients with asthma is the result of a spectrum of immune responses rather than a dichotomy of T2 or non-T2 inflammation, where multiple pathways may be active.

Original language	English
Article number	2102669
Journal	European Respiratory Journal
Volume	59
Issue number	2
Early online date	17 Feb 2022
DOIs	https://doi.org/10.1183/13993003.02669-2021
Publication status	Published - Feb 2022

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1183/13993003.02669-2021

Cite this

@article{10483e25594f41b9abc098e07644d530,

title = "The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm",

abstract = "It is increasingly evident that the airway inflammatory environment in patients with asthma is the result of a spectrum of immune responses rather than a dichotomy of T2 or non-T2 inflammation, where multiple pathways may be active.",

author = "Seys, {Sven F.} and Long, {Merete B.}",

year = "2022",

month = feb,

doi = "10.1183/13993003.02669-2021",

language = "English",

volume = "59",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "2",

}

TY - JOUR

T1 - The quest for biomarkers in asthma

T2 - challenging the T2 versus non-T2 paradigm

AU - Seys, Sven F.

AU - Long, Merete B.

PY - 2022/2

Y1 - 2022/2

N2 - It is increasingly evident that the airway inflammatory environment in patients with asthma is the result of a spectrum of immune responses rather than a dichotomy of T2 or non-T2 inflammation, where multiple pathways may be active.

AB - It is increasingly evident that the airway inflammatory environment in patients with asthma is the result of a spectrum of immune responses rather than a dichotomy of T2 or non-T2 inflammation, where multiple pathways may be active.

U2 - 10.1183/13993003.02669-2021

DO - 10.1183/13993003.02669-2021

M3 - Review article

C2 - 35177484

SN - 0903-1936

VL - 59

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 2

M1 - 2102669

ER -

The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm

Abstract

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this